UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051332
Receipt number R000058555
Scientific Title Developing a computer-adaptive screening test of child and adolescent psychiatric diseases
Date of disclosure of the study information 2023/07/01
Last modified on 2023/06/13 17:50:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Developing a computer-screening of child mental health

Acronym

Developing the C-CAT

Scientific Title

Developing a computer-adaptive screening test of child and adolescent psychiatric diseases

Scientific Title:Acronym

Developing the C-CAT

Region

Japan


Condition

Condition

child and adolescent mental disorders

Classification by specialty

Psychiatry Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This research aims to develop a CAT easily accessible that is designated for most common mental disorders in children and adolescents.

Basic objectives2

Others

Basic objectives -Others

In order to address the problem of child and adolescent mental disorders being underidentified screening instruments are needed to help identify the disorders with high accuracy and to aid facilitating access to specialized care. A computer-adaptive test (CAT) based on an item-response theory is such a screening test most feasible at present. This research aims to develop a CAT easily accessible that is designated for most common mental disorders in children and adolescents.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Criterion validity: area under the ROC curve (AUC) for the gold-standard diagnosis
Construct validity: correlation coefficients with external questionnaire scores
Test--retest reliability: intraclass correlation coefficients

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

18 years-old >=

Gender

Male and Female

Key inclusion criteria

1) aged 6 to 18 years
2) Japanese-speaking psychiatric patients or healthy children whose legal guardians are also Japanese speakers.
3) participants or their parents with written informed consent

Key exclusion criteria

1)patients with physical illnesses requiring urgent treatment (e.g., severe anorexia nervosa)
2)partipants whose parents or caregivers cannot communicate appropriately (e.g.,due to mental retardation)
3)when the investigators determine that inclusion to the study is not appropriate for other reasons

Target sample size

1200


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Nishiyama

Organization

Nagoya City University Graduate School of Medicine

Division name

Department of Public Health

Zip code

467-8601

Address

Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan

TEL

0528538176

Email

p-gen@umin.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Nishiyama

Organization

Nagoya City University Graduate School of Medicine

Division name

Department of Public Health

Zip code

467-8601

Address

Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan

TEL

0528538176

Homepage URL


Email

p-gen@umin.ac.jp


Sponsor or person

Institute

Nagoya City University

Institute

Department

Personal name

Takeshi Nishiyama


Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Management Center, Nagoya City University Hospital

Address

Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan

Tel

052-858-7215

Email

clinical_research@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋市立大学病院(愛知県),名古屋大学医学部附属病院(愛知県),福井大学病院(福井県),上林記念病院(愛知県)


Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 03 Month 14 Day

Date of IRB

2023 Year 05 Month 17 Day

Anticipated trial start date

2024 Year 07 Month 01 Day

Last follow-up date

2027 Year 10 Month 31 Day

Date of closure to data entry

2027 Year 10 Month 31 Day

Date trial data considered complete

2027 Year 10 Month 31 Day

Date analysis concluded

2028 Year 03 Month 31 Day


Other

Other related information

nothing special


Management information

Registered date

2023 Year 06 Month 13 Day

Last modified on

2023 Year 06 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058555


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name